Literature DB >> 9294776

Is the persistence of isolated GH deficiency in adulthood predicted by anatomical hypothalamic-pituitary alterations?

S Vannelli1, B Stasiowska, J Bellone, G Aimaretti, S Bellone, T Avataneo, S Cirillo, L Benso.   

Abstract

The aim of this study was to verify the persistence in adulthood of GH deficiency diagnosed in childhood and treated with hGH in childhood and to study whether anatomical hypothalamic-pituitary alterations evaluated by magnetic resonance (MR) imaging could predict it. To this goal, in six GHD adults (3 males and 3 females aged 17.2-24.5 yr, BMI 21.8 +/- 1.3), we studied anterior pituitary hormone response to GHRH (1 microgram/kg iv)+pyridostigmine (120 mg po)+ GnRH (100 micrograms iv) +TRH (400 micrograms iv)+hCRH (100 micrograms iv) as well as brain MR imaging. In childhood, the diagnosis of severe isolated GHD had been done based on auxological findings as well as on GH response < 7 micrograms/L after two classical provocative stimuli. In the present study, hormonal responses showed the persistence of severe isolated GHD in 4 out of 6 patients (peak, mean +/- SEM: 3.8 +/- 0.6, range 2.6-4.8 micrograms/L). In these patients, IGF-I levels were found low or low-normal. In other 2 patients, a clear GH response to stimulation (peak: 51.3 and 43.0 micrograms/L, respectively) together with normal IGF-I levels were found. No other anterior pituitary hormone deficiency was present in all subjects. MR imaging showed pituitary hypoplasia in all patients with persistent GHD; in 2 out of them, pituitary stalk interruption and ectopic neurohypophysis was also present. On the other hand, MR imaging showed normal hypothalamo-pituitary morphology in the 2 subjects with normal somatotrope response. In conclusion, our present data indicate that testing with a potent stimulus such as GHRH+pyridostigmine is a reliable method to assess the persistence of GH deficiency which associates with anatomical hypothalamic-pituitary alterations at the MR imaging. Patients with transient GH deficiency in childhood and normal pituitary GH reserve in adulthood have normal hypothalamic-pituitary MR imaging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9294776     DOI: 10.1007/BF03350309

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  45 in total

1.  [MRI exploration of the hypothalamo-hypophyseal axis].

Authors:  M Braun; J Roland; C Moret; L Picard
Journal:  Ann Endocrinol (Paris)       Date:  1992       Impact factor: 2.478

2.  Growth hormone deficiency in children: role of magnetic resonance imaging in assessing aetiopathogenesis and prognosis in idiopathic hypopituitarism.

Authors:  C Pellini; B di Natale; R De Angelis; N Bressani; G Scotti; F Triulzi; G Chiumello
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

3.  A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.

Authors:  E Ghigo; E Imperiale; G M Boffano; E Mazza; J Bellone; E Arvat; M Procopio; S Goffi; A Barreca; P Chiabotto
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

Review 4.  Clinical aspects of growth hormone deficiency in adults.

Authors:  H de Boer; G J Blok; E A Van der Veen
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

5.  Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.

Authors:  E Ghigo; J Bellone; G Aimaretti; S Bellone; S Loche; M Cappa; E Bartolotta; F Dammacco; F Camanni
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

6.  A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency.

Authors:  W F Blum; M B Ranke; K Kietzmann; E Gauggel; H J Zeisel; J R Bierich
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

7.  Do short children secrete insufficient growth hormone?

Authors:  Z Zadik; S A Chalew; S Raiti; A A Kowarski
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

Review 8.  Human growth hormone and human aging.

Authors:  E Corpas; S M Harman; M R Blackman
Journal:  Endocr Rev       Date:  1993-02       Impact factor: 19.871

9.  Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient.

Authors:  E Cacciari; P Tassoni; A Cicognani; P Pirazzoli; S Salardi; A Balsamo; A Cassio; S Zucchini; C Colli; D Tassinari
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

10.  Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.

Authors:  W J Smith; T J Nam; L E Underwood; W H Busby; A Celnicker; D R Clemmons
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.